23and me stock.

The 23andMe IPO price was $10 per share which is typical for SPACs, and the 23andMe IPO date was chosen to be June 17. The combined company was renamed to 23andMe Holding Co. and began trading on the Nasdaq stock market under the ticker symbol “ME”. The stock rose to $13.32 at the end of the day, which is +30% upside to …Key Data. Open $0.9108. Day Range 0.8750 - 0.9169. 52 Week Range 0.6101 - 3.4800. Market Cap $429.09M. Shares Outstanding 311.61M. Public Float 274.92M. Beta 1.77. Rev. per Employee $331.10K.Nov 27, 2023 · 2 Wall Street research analysts have issued 1-year price objectives for 23andMe's shares. Their ME share price targets range from $1.75 to $7.00. On average, they anticipate the company's stock price to reach $4.38 in the next year. This suggests a possible upside of 381.4% from the stock's current price. Track 23andMe Holding Co - Ordinary Shares - Class A (ME) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Mar 1, 2023 · I would rate 23andMe a buy rating. Although the stock price is a bit shaky and volatile, when thinking about the long term, the company has high potential to be big in the genomics testing space ...

Find the latest 23andMe Holding Co. (ME) stock quote, history, news and other vital information to help you with your stock trading and investing.The 23andMe IPO will proceed using the increasingly popular SPAC approach, and the deal is expected to be finalized in the Q2 of 2021. The company, as a result of going to market, will hold a $3.5 billion valuation. Meanwhile, 81% of the company’s shares will be owned by current shareholders, and both Branson and 23andMe Co-Founder and CEO ...To be assigned a Value Score, stocks must have a valid (non-null) ratio and corresponding ranking for at least two of the six valuation ratios. Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are a good value and so on. 23andMe Holding Co. has a Value Score of 51, which is Average.

See the company profile for 23andMe Holding Co. (ME) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their ...

Genetic-testing company and researcher 23andMe Holding ( ME 5.77%) wasn't testing very well with investors on Wednesday. They assertively sold out of the company's shares, to the point where the ...Achieved FY2022 financial guidance. Fourth quarter and full year revenues of $101 million and $272 million representing 14% and 11% increases over prior year, respectively. New genomic health services expected in FY2023. Webcast today, May 26, 2022, at 4:30 p.m. Eastern Time.23andMe Holding Co. is a publicly held personal genomics and biotechnology company based in South San Francisco, ... The combined company was renamed to 23andMe …Open a brokerage account and deposit funds in it to purchase stock in a company, explains the Wall Street Journal. Companies such as Charles Schwab, E-Trade, and Ameritrade provide brokerage services.

Q3 2024 EPS Estimate Trends. Current. -$0.15. 1 Month Ago. -$0.15. 3 Months Ago. -$0.18. 23andMe Holding Co. analyst estimates, including ME earnings per share estimates and analyst recommendations.

I would rate 23andMe a buy rating. Although the stock price is a bit shaky and volatile, when thinking about the long term, the company has high potential to be big in the genomics testing space ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.EXPLANATORY NOTE . This Registration Statement on Form S-8 (the “Registration Statement”), relating to the 23andMe Holding Co. 2021 Incentive Equity Plan (the “Equity Plan”) and the 23andMe Holding Co. Employee Stock Purchase Plan (the “ESPP” and, together with the Equity Plan, the “Plans”), is being filed pursuant to General Instruction E to Form S-8, for the purpose of ...See the latest 23andMe Holding Co Class A stock price (ME:XNAS), related news, valuation, dividends and more to help you make your investing decisions.A. The latest price target for 23andMe Holding ( NASDAQ: ME) was reported by Citigroup on Thursday, August 10, 2023. The analyst firm set a price target for 1.75 expecting ME to rise to within 12 ...23andMe is going public by merging with Richard Branson's SPAC, VG Acquisition Corp. The deal will value the consumer genetics and research company at around $3.5 billion.

23andMe price target lowered to $3 from $5 at TD Cowen November 9, 2023TipRanks. Analysts Conflicted on These Healthcare Names: Sana Biotechnology (SANA), 23andMe Holding (ME) and Invitae (NVTA ...Stock Price Forecast. The 3 analysts offering 12-month price forecasts for 23andMe Holding Co. have a median target of 3.00, with a high estimate of 6.00 and a low estimate of 0.90. The median ... Track 23andMe Holding Co - Ordinary Shares - Class A (ME) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Meanwhile, at VGAC’s current stock price, 23andMe is valued at around $4.56 billion. After adjusting for its pro forma $984 million net cash, it would have an EV (enterprise value) of $3.58 ...Feb 8, 2023 · FY2023 Financial Guidance. 23andMe is raising its full year guidance following Q3 FY2023 results. Full year revenue for fiscal year 2023, which will end on March 31, 2023, is projected to be in the range of $290 to $300 million, with a net loss in the range of $325 to $335 million. The full year Adjusted EBITDA deficit is projected to be in the ... 4 de fev. de 2021 ... SirRichardBranson #23andMe #SPAC Virgin Group Founder Sir Richard Branson and 23andMe CEO & Co-Founder Annew Wojcicki join Yahoo Finance to ...Majority of impacted users are now being notified, 23andMe confirmed. It's now been confirmed that an additional 6.9 million 23andMe users had ancestry data …

ME. +11.44%. Shares of 23andMe Holding Co. were falling more than 7% in premarket trading Friday after the DNA-testing company disclosed that Chief Financial Officer Stevem Schoch was resigning ...

Q3 2024 EPS Estimate Trends. Current. -$0.15. 1 Month Ago. -$0.15. 3 Months Ago. -$0.18. 23andMe Holding Co. analyst estimates, including ME earnings per share estimates and analyst recommendations.The Wall Street analyst predicted that 23andme Holding Co's share price could reach $1.75 by Aug 10, 2024. The average 23andme Holding Co stock price prediction ...30 de nov. de 2021 ... Investors could be in for a big win should 23andMe find a way to lead this future, but so far the company has failed to excite them. One primary ...23andMe Holding Co. ( ME) has fallen Thursday morning, with the stock losing -1.80% in pre-market trading to 1.64. ME's short-term technical score of 20 indicates that the stock has traded less bullishly over the last month than 80% of stocks on the market. In the Diagnostics & Research industry, which ranks 124 out of 146 industries, 23andMe ...Hackers stole personal data belonging to 6.9 million people who used services from the genetic testing company 23andMe in October, a company …23andMe Holding Co. (NASDAQ:ME) Q2 2024 Earnings Call Transcript. 23andMe Holding Co. (NASDAQ:ME) Q2 2024 Earnings Call Transcript November 8, 2023 23andMe …

6 de set. de 2023 ... 23andMe Holding Co. (ME) stock is down -66.15% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.

So, when comparing one stock to another in a different industry, it's best make relative comparisons to that stock's respective industry values. -124.34% -224.88%

Achieved FY2023 financial guidance FY2023 full year revenue grew 10% over prior year Webcast today, May 25, 2023 at 4:30 p.m. Eastern Time SOUTH SAN FRANCISCO, Calif., May 25, 2023 (GLOBE NEWSWIRE ...What is 23andMe's consensus rating and price target? According to the issued ratings of 1 analysts in the last year, the consensus rating for 23andMe stock is Buy based on the current 1 buy rating for ME. The average twelve-month price prediction for 23andMe is $1.75 with a high price target of $1.75 and a low price target of $1.75.msn.com - November 23 at 5:36 PM. Make Empowered Decisions with 23andMe Health + Ancestry Service, 57% Off for Black Friday. msn.com - November 21 at 1:15 PM. 23andMe and AncestryDNA kits are nearly half-off on Amazon Canada for Black Friday. uk.news.yahoo.com - November 20 at 7:52 PM.Personalized medicine and at-home genetic testing kit company 23andMe went public on Thursday through a merger with a Richard Branson SPAC, VG Acquisition Corp., in a deal that raised near-$600 ...Nov 20, 2023 · November 16, 2023. $0.76. 3,664,420. 1:1. $0.86. $0.86. $0.75. NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown. The Split Adjustment Factor is a cumulative factor which encapsulates all splits since ... Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...Nov 8, 2023 · SOUTH SAN FRANCISCO, Calif. (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, reported its financial results for the second quarter of ... 23andMe (ME) stock fell about 7 percent on July 6 and closed just above $10. The stock is down more than 40 percent from its all-time high. Is it a good time to buy the dip in 23andMe stock near ...May 1, 2023 at 11:54 AM · 2 min read. 23andMe co-founder and CEO Anne Wojcicki sees a much bigger presence for her DNA decoding company in the pharma space. "The end of the GSK collaboration ...Anne Wojcicki, co-founder and chief executive officer of 23andme. Some 6.9 million 23andMe customers had their data compromised after an anonymous hacker …

23andMe Holding Co. Class A Common Stock (ME) Stock Price, Quote, News & History | Nasdaq MY QUOTES: ME Edit my quotes 23andMe Holding Co. Class A Common …23andMe Holding Third Quarter 2023 ResultsKey Financial Results. Revenue: US$66.9m (up 18% from 3Q 2022). Net loss: US$92.0m (loss widened by 2.9% from 3Q 2022). US$0.20 loss per share.A high-level overview of 23andMe Holding Co. (ME) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.ME | 28 minutes ago. NEW YORK, NY / ACCESSWIRE / December 4, 2023 / 23andMe, a popular personal genomics and DNA analysis company run by 23andMe Holding Co. ("23 and Me") (NASDAQ:ME), recently suffered a massive data leak. The attack targeted the personal information of 23andMe users -more than 4 million people- compromising individual's ...Instagram:https://instagram. how to buy hederabest bank to open an account in californiashort term health insurance oregonvanguard vusxx Jun 18, 2021 · The SPAC merger gave 23andMe an equity value of $4.45 billion, and its stock surge boosted its equity value to around $5.92 billion. After adjusting for its $984 million in pro forma net cash, we ... forex trading in thinkorswimnyse nly g What we do know is this: In its most recent financial report, 23andMe reported trailing-12-month sales of $306 million, down 31% year over year. The company earned no profit -- losing $251 million ...The 23andMe IPO will proceed using the increasingly popular SPAC approach, and the deal is expected to be finalized in the Q2 of 2021. The company, as a result of going to market, will hold a $3.5 billion valuation. Meanwhile, 81% of the company’s shares will be owned by current shareholders, and both Branson and 23andMe Co-Founder and CEO ... stock option trading app Under the merger agreement, the purchase price is $400 million (subject to certain customary downward adjustments), of which 25% will be paid in cash and 75% in shares of 23andMe Class A Common Stock. The acquisition is expected to close by the end of 2021. The acquisition adds Lemonaid Health’s innovative telemedicine and …If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...